Influenza Vaccination for Flu Prevention in Patients With Plasma Cell Disorders

NCT04080531 PHASE4 COMPLETED Results posted

This phase IV trial studies how well influenza vaccination works in preventing infections such as influenza in patients with plasma cell disorders. Influenza infections may theoretically support the growth of tumor cells and improving protection against influenza may improve the status of patients' plasma cell disorder. Giving influenza vaccination may reduce influenza-related complications including infections, hospitalizations, and deaths, and improve the status of plasma cell disorders.

Details

Lead sponsor	Emory University
Phase	PHASE4
Status	COMPLETED
Enrolment	165
Start date	Fri Oct 18 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Thu Dec 15 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• Plasma Cell Neoplasm

Interventions

• Pneumococcal 13-valent Conjugate Vaccine
• Trivalent Influenza Vaccine

Countries

United States